Novo Nordisk reported DKK59.62B in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Bausch Health Companies USD 489M 230M Mar/2026
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Eli Lilly USD 9.78B 792M Mar/2026
GlaxoSmithKline GBP 2.29B 856M Mar/2026
Merck USD -1.88B 8.12B Mar/2026
Novartis USD 4.24B 171M Mar/2026
Novo Nordisk DKK 59.62B 27.24B Mar/2026
Novo Nordisk DKK 5.18B 33.61B Jun/2025
Pacira USD 4.62M 1.43M Mar/2026
Sanofi EUR 1.94B 239M Mar/2026
Supernus Pharmaceuticals USD -35.25M 49.07M Mar/2026